-
1 Comment
Nova Eye Medical Limited is currently in a long term uptrend where the price is trading 12.5% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.
Based on the above factors, Nova Eye Medical Limited gets an overall score of 2/5.
ISIN | AU0000094252 |
---|---|
Industry | Medical Devices |
Sector | Healthcare |
CurrencyCode | AUD |
Exchange | AU |
PE Ratio | 2.86 |
---|---|
Market Cap | 102M |
Beta | 0.62 |
Dividend Yield | 0.0% |
Target Price | 1.69 |
Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ELX.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024